With drugs on the horizon for treating and possibly preventing transthyretin amyloid cardiomyopathy, cardiologists are ...

AI models trained on optical coherence tomography scans to detect eye diseases are showing promise in diagnosing heart ...

Nanoscope Therapeutics has said it plans to seek regulatory approval for its advanced retinitis pigmentosa gene therapy MCO-010 early this year.

The Series B financing will support an upcoming clinical trial in New Zealand of the company's lead program, EPI-321, in facioscapulohumeral muscular dystrophy.